Neuronetics (STIM) Net Cash Flow Growth (5y) (2022 - 2026)
Neuronetics (STIM) Net Cash Flow Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn |
| 10 | Neuronetics | 123.87 Mn | 117.86 Mn | 16.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.18% |
| Dec 31, 2025 | 27.83% |
| Sep 30, 2025 | 48.34% |
| Jun 30, 2025 | 17.19% |
| Mar 31, 2025 | 16.50% |
| Dec 31, 2024 | 26.72% |
| Sep 30, 2024 | 5.77% |
| Jun 30, 2024 | 4.79% |
| Mar 31, 2024 | -7.20% |
| Dec 31, 2023 | 66.89% |
| Sep 30, 2023 | -16.10% |
| Jun 30, 2023 | -10.42% |
| Mar 31, 2023 | -11.12% |
| Dec 31, 2022 | -21.72% |
| Sep 30, 2022 | 27.18% |